RMD Open | Publishes peer-reviewed original research on the full spectrum of musculoskeletal disorders, rheumatism and connective tissue diseases.

Intro Widget

RMD Open publishes high quality peer-reviewed original research covering the full spectrum of musculoskeletal disorders, rheumatism and connective tissue diseases, including osteoporosis, spine and rehabilitation. Clinical and epidemiological research, basic and translational medicine, interesting clinical cases, and smaller studies that add to the literature are all considered.

It is an online only open access journal that aims to provide rapid publication of research through a continuous publication model. All submitted content is subject to peer review prior to publication. Published work is free to read.

RMD Open is an official journal of EULAR.

Scopus CiteScore: 3.47 (2017)

Editor-in-Chief: Professor Bernard Combe, CHU Lapeyronie, France
Editorial team

Authors

RMD Open considers submissions of a variety of article types, including original articles, short reports and clinical cases.

Information is also provided on editorial policies and open access.

This is an open access journal that levies an Article Publishing Charge (APC). Discounts and waivers are available; details are provided in the Author Information section.

All manuscripts should be submitted online.

Published articles are discoverable via PubMed, Scopus and Google Scholar.

Author information

Submit a paper

Intro Widget

Authors

Latest Articles

Psoriatic arthritis:

Ixekizumab is efficacious when used alone or when added to conventional synthetic disease-modifying antirheumatic drugs (cDMARDs) in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor inhibitors

Early arthritis:

Development of clinically apparent synovitis: a longitudinal study at the joint level during progression to inflammatory arthritis

Correction:

Correction: Secukinumab in the treatment of psoriatic arthritis: efficacy and safety results through 3 years from the year 1 extension of the randomised phase III FUTURE 1 trial

Spondyloarthritis:

Can power Doppler ultrasound of the entheses help in classifying recent axial spondyloarthritis? Data from the DESIR cohort

Autoimmunity:

Characteristics and treatment of new-onset arthritis after checkpoint inhibitor therapy

Most Read Articles

Crystal arthropathies:

Gout and the risk of incident atrial fibrillation in older adults: a study of US Medicare data

Imaging:

Imaging in diagnosis, outcome prediction and monitoring of large vessel vasculitis: a systematic literature review and meta-analysis informing the EULAR recommendations

Rheumatoid arthritis:

Which patients presenting with arthralgia eventually develop rheumatoid arthritis? The current state of the art

Connective tissue diseases:

EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a methodology report

Osteoarthritis:

Towards secondary prevention of early knee osteoarthritis

Altmetrics

Related Journals